New Jersey CyberKnife Wins Award of Excellence

 

New Jersey CyberKnife recently won the Award of Excellence at Alliance Oncology’s 2017 Division Meeting. The annual meeting was held April 12 – 14 at the Sheraton Grand in downtown Nashville, Tennessee. The Award of Excellence is bestowed to the top radiation oncology center in the company and was presented by the Senior Vice President […]

 

Learn More

 

 

Understanding Clinical Trials

 

The future of cancer treatment has never been so promising.  Many advances in cancer treatments are being announced every day and even more treatment options that have the potential to improve the health of cancer patients are currently in development in medical facilities across the country.  As part of the development and approval process, it […]

 

Learn More

 

 

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

 

According to research presented at the recent 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), high dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates.  The Cyberknife at New Jersey Cyberknife delivers SBRT.  Although […]

 

Learn More

 

 

New Jersey CyberKnife and Community Medical Center to Host Educational Dinner Program

 

 

Learn More

 

 

Happy Halloween!

 

 

Learn More

 

 

Breast Center Receives Accreditation from the National Accreditation Program for Breast Centers

 

The Breast Center at the J. Phillip Citta Regional Cancer Center has been granted a three year full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons.  The NAPBC represents a consortium of national, professional organizations dedicated to the improvement of the quality of […]

 

Learn More

 

 

Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches

 

Researchers from the National Cancer Institute, the U.S. government’s principal agency for cancer research, have developed a risk model-based approach for selecting smokers and former smokers who may be candidates for lung cancer screening with low-dose computed tomography (CT).   Using data from two lung cancer screening studies and a U.S. health survey, the researchers […]

 

Learn More

 

 

Screening Strategy May Predict Lethal Prostate Cancer Later in Life

 

A recent study found that mid-life prostate-specific antigen (PSA) levels predict who will be more likely to develop lethal prostate cancer.  Investigators from Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health found that measuring PSA levels in younger men (between the ages of 40 and 59) could accurately predict future […]

 

Learn More

 

 

New Jersey CyberKnife Patient Speaks at Cancer Survivorship Event

 

 

Learn More

 

 

New Decision Aids Support Shared Decision Making for Lung Cancer Screening

 

According to the American Cancer Society’s Cancer Facts & Figures 2016 report, almost 4,000 people will die from lung cancer in New Jersey this year.  One way to lower this number is by increasing the number of lung cancer screenings.  For some adults, annual lung cancer screening could lead to an early diagnosis and life-saving […]

 

Learn More